Charles River Laboratories International, Inc. (NYSE: CRL) provides essential drug discovery, non-clinical development, safety assessment, and manufacturing solutions to the pharmaceutical, biotechnology, and medical device industries world…
HQ: Wilmington, MA, United States of Americawww.criver.com
USD278.26+1.93%vs prev. close
Market snapshot
Price
USD278.26
Daily move
+1.93%
P/E
—
EPS TTM
-4.81
Dividend yield
—
Beta
1.41
Market cap
13.4B
Price history
CRL price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Charles River Labs
CRL
Diagnostics & Research
13.4
—
—
-3.5%
-2.1%
+48.4%
+79.0%
+74.2%
+39.5%
🔒
Subscribe to Equity Analytics to compare CRL with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.